Protein C and S Activity with Reflex to Protein C and/or S Antigen

Test Code
7942


CPT Codes
85303, 85306

Includes
If Protein C Activity is <70%, then Protein C Antigen will be performed at an additional charge (CPT code(s): 85302).
If Protein S Activity is <70% for males or <60% for females, then Protein S Antigen will be performed at an additional charge (CPT code(s): 85305).


Preferred Specimen
2 mL frozen citrated platelet-poor plasma (x2) collected in separate 3.2% sodium citrate (light blue-top) tubes


Minimum Volume
1 mL (x2)


Instructions
Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.


Transport Container
Plastic vials


Transport Temperature
Frozen


Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis


Methodology
See inidividual tests

Setup Schedule
Set up and Report available: See individual tests


Reference Range
Protein C Activity70-180 % normal
Protein S Activity
    Male70-150 % normal
    Female60-140 % normal
  
  Protein C Antigen70-140 % normal
  Protein S Antigen70-140 % normal


Clinical Significance
Aids in characterization of protein C (PC) and/or protein S (PS) deficiency. PC and PS deficiency is associated with increased thrombotic risk and may be congenital or acquired. Acquired PC and PS deficiency may occur with vitamin K antagonists/deficiency, liver disease, malignancy, consumptive DIC, surgery, trauma, and hepatic immaturity of the newborn. In addition, PS deficiency is physiologic in pregnancy.

Anticoagulant interference: Expected impact by therapeutic levels (potential interference depends upon drug concentration): Warfarin: decrease; Heparin (UFH or LMWH): no effect to falsely increased activity levels at higher levels; Dabigatran or Argatroban (Thrombin Inhibitors): may falsely increase activity; Rivaroxaban, Apixaban, Edoxaban (Factor Xa Inhibitors): may falsely increase activity.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.